BACKGROUND AND OBJECTIVES: A male infant with a family history of thrombotic microangiopathy developed atypical hemolytic uremic syndrome (aHUS). DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Case report. RESULTS: Genetic analysis demonstrated a heterozygous mutation (S1191L) of CFH, the gene coding complement factor H (CFH). The child suffered many episodes of HUS, each treated with plasma exchange. In time, despite initiation of a prophylactic regimen of plasma exchange, his renal function declined significantly. At the age of 4 yr he received a (split liver) combined liver-kidney transplant (LKT) with preoperative plasma exchange and enoxaparin anticoagulation. Initial function of both grafts was excellent and is maintained for nearly 2 yr. CONCLUSIONS: This report adds to the small but growing number of individuals in whom LKT has provided a favorable outcome for aHUS associated with CFH mutation, expands the technique of using a split liver graft, and describes the unique histologic features of subclinical liver disease in HUS.
BACKGROUND AND OBJECTIVES: A male infant with a family history of thrombotic microangiopathy developed atypical hemolytic uremic syndrome (aHUS). DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Case report. RESULTS: Genetic analysis demonstrated a heterozygous mutation (S1191L) of CFH, the gene coding complement factor H (CFH). The child suffered many episodes of HUS, each treated with plasma exchange. In time, despite initiation of a prophylactic regimen of plasma exchange, his renal function declined significantly. At the age of 4 yr he received a (split liver) combined liver-kidney transplant (LKT) with preoperative plasma exchange and enoxaparin anticoagulation. Initial function of both grafts was excellent and is maintained for nearly 2 yr. CONCLUSIONS: This report adds to the small but growing number of individuals in whom LKT has provided a favorable outcome for aHUS associated with CFH mutation, expands the technique of using a split liver graft, and describes the unique histologic features of subclinical liver disease in HUS.
Authors: J Y Scoazec; G Borghi-Scoazec; F Durand; J Bernuau; B N Pham; J Belghiti; G Feldmann; C Degott Journal: Gastroenterology Date: 1997-03 Impact factor: 22.682
Authors: R B Miller; B A Burke; W J Schmidt; K J Gillingham; A J Matas; M Mauer; C E Kashtan Journal: Nephrol Dial Transplant Date: 1997-07 Impact factor: 5.992
Authors: R Centurioni; E Bobbio-Pallavicini; C Porta; F Rodeghiero; L Gugliotta; A Billio; F Tacconi; E Ascari Journal: Haematologica Date: 1995 Jul-Aug Impact factor: 9.941
Authors: D Ducloux; J M Rebibou; S Semhoun-Ducloux; M Jamali; V Fournier; C Bresson-Vautrin; J M Chalopin Journal: Transplantation Date: 1998-05-27 Impact factor: 4.939
Authors: N Rougier; M D Kazatchkine; J P Rougier; V Fremeaux-Bacchi; J Blouin; G Deschenes; B Soto; V Baudouin; B Pautard; W Proesmans; E Weiss; L Weiss Journal: J Am Soc Nephrol Date: 1998-12 Impact factor: 10.121
Authors: T E Mollnes; K Høgåsen; C De Carolis; E Vaquero; E W Nielsen; L Fontana; R Perricone Journal: Scand J Immunol Date: 1998-09 Impact factor: 3.487
Authors: M Noris; P Ruggenenti; A Perna; S Orisio; J Caprioli; C Skerka; B Vasile; P F Zipfel; G Remuzzi Journal: J Am Soc Nephrol Date: 1999-02 Impact factor: 10.121
Authors: Marina Noris; Jessica Caprioli; Elena Bresin; Chiara Mossali; Gaia Pianetti; Sara Gamba; Erica Daina; Chiara Fenili; Federica Castelletti; Annalisa Sorosina; Rossella Piras; Roberta Donadelli; Ramona Maranta; Irene van der Meer; Edward M Conway; Peter F Zipfel; Timothy H Goodship; Giuseppe Remuzzi Journal: Clin J Am Soc Nephrol Date: 2010-07-01 Impact factor: 8.237
Authors: Carla Nester; Zoe Stewart; David Myers; Jennifer Jetton; Ramesh Nair; Alan Reed; Christie Thomas; Richard Smith; Patrick Brophy Journal: Clin J Am Soc Nephrol Date: 2011-05-26 Impact factor: 8.237
Authors: Samhar I Al-Akash; P Stephen Almond; Van H Savell; Salam I Gharaybeh; Cris Hogue Journal: Pediatr Nephrol Date: 2010-12-02 Impact factor: 3.714